Skip to main content
TipRanks
Go Ultimate75% OFF

Rapid Nutrition (0RNS) AI Stock Analysis

0 Followers
GB:0RNS

Rapid Nutrition

(LSE:0RNS)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
TTM Revenue ReboundThe TTM revenue rebound indicates that the company has recently regained some commercial traction after a difficult period. If maintained, stronger sales could improve operating leverage, support better capacity utilization, and provide a foundation for rebuilding profitability over the next several quarters.
Negative Factors
Persistent UnprofitabilityPersistent losses and a negative net margin show that the current business model is not yet converting revenue into sustainable earnings. Continued unprofitability limits internally generated capital, weakens resilience, and makes future performance dependent on a successful operational turnaround.

Rapid Nutrition (0RNS) vs. iShares MSCI United Kingdom ETF (EWC)

-100%-50%0%50%100%150%200%GB:0RNS-62.05%EWC+21.04%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 10.53M
Dividend Yield
―
Average Volume (3M)
1,804
Price to Earnings (P/E)
-0.7
Beta (1Y)
1.10
Revenue Growth
-41.21%
EPS Growth
73.08%
Country
UK
Employees
3
Sector
General
Sector Strength
55
Industry
Packaged Foods

Rapid Nutrition Business Overview & Revenue Model

Company Description

Rapid Nutrition PLC is a natural healthcare enterprise that researches, develops, and manufactures a diverse portfolio of science-backed health and wellness products. Its market presence extends across the United Kingdom, Australia, Asia, the United...

Rapid Nutrition Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

GB:0RNS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:BLCFR:BLC68NeutralEUR 146.11M2.5149.70%―-1.79%10979.07%
FR:BOIFR:BOI65NeutralEUR 333.73M12.886.82%7.03%-1.80%35.22%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
FR:ALFLEFR:ALFLE50NeutralEUR 98.62M10.217.40%14.26%4.46%133.27%
FR:SAVEFR:SAVE48NeutralEUR 787.24M9.884.13%2.46%-1.53%-12.97%
FR:BONFR:BON44NeutralEUR 284.26M19.21-3.09%2.77%-0.80%―

* General Sector Average

Performance Comparison

-50%0%50%100%150%GB:0RNSFR:BLCFR:BOIFR:BONFR:ALFLEFR:SAVEDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:0RNS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0RNSRapid Nutrition1.67-2.73-62.05%
FR:BLCBastide le Confort Medical19.88-6.22-23.83%
FR:BOIBoiron SA19.20-6.48-25.24%
FR:BONBonduelle SA9.030.273.13%
FR:ALFLEFleury Michon23.70-0.04-0.15%
FR:SAVESavencia SA56.80-1.48-2.53%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.